White House preps to pump billions into mRNA vaccine manufacturing capacity — but Moderna and Pfizer will have to buy in

The White House released early details this week on its plan to pump billions of new dollars in mRNA vaccine manufacturing to increase the number of doses abroad and prepare for the next pandemic too.

“Importantly, initial production could provide more mRNA COVID vaccines for the world,” coronavirus response coordinator Jeffrey Zients said Thursday at a media briefing. “The goal of this program is to expand existing capacity by an additional billion doses per year, with production starting by the second half of 2022.”